Trials / Unknown
UnknownNCT02148900
Development of a Blood Test for Marfan Syndrome
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 336 (estimated)
- Sponsor
- Shriners Hospitals for Children · Academic / Other
- Sex
- All
- Age
- 4 Years – 26 Years
- Healthy volunteers
- Accepted
Summary
The objective of this study is to determine whether a simple blood test can be a useful clinical tool for monitoring aortic disease in Marfan syndrome and Marfan-related disorders.
Detailed description
The primary objective of this study is to determine whether increased quantitites of circulating microfibril fragments, measured with a simple blood test, are associated with aortic root size and increased growth of the aortic root in Marfan syndrome and related disorders. The secondary objectives of this study are to: (1) Determine a Marfan "signature" profile of circulating microfibril fragments. (2) Determine if high concentrations of fibrillin-1 fragments are associated with large aortic root diameters. (3) Determine which fibrillin-1 fragments are good biomarkers for aortic root growth and size in Marfan syndrome. (4) Determine the relation between fibrillin-1, aortic root diameter, and medical and lifestyle factors reported on questionnaires.
Conditions
Timeline
- Start date
- 2013-05-01
- Primary completion
- 2017-12-01
- Completion
- 2017-12-01
- First posted
- 2014-05-28
- Last updated
- 2017-01-05
Locations
5 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT02148900. Inclusion in this directory is not an endorsement.